Ray Dalio's EHC Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 57,798 shares of Encompass Health Corporation (EHC) worth $7.34 M, representing 0.03% of the portfolio. First purchased in 2021-Q1, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in EHC, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2021, adding 99,992 shares. Largest reduction occurred in Q1 2024, reducing 42,923 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Encompass Health Corporation (EHC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Encompass Health Corporation (EHC) Trades by Ray Dalio
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2021 | +3,153 | New Buy | 3,153 | $81.83 |
| Q2 2021 | +99,992 | Add 3171.33% | 103,145 | $78.03 |
| Q3 2021 | -13,588 | Reduce 13.17% | 89,557 | $75.04 |
| Q4 2021 | +17,833 | Add 19.91% | 107,390 | $65.26 |
| Q1 2022 | +39,129 | Add 36.44% | 146,519 | $71.11 |
| Q2 2022 | +15,868 | Add 10.83% | 162,387 | $56.05 |
| Q3 2022 | -3,073 | Reduce 1.89% | 159,314 | $45.23 |
| Q4 2022 | -37,943 | Reduce 23.82% | 121,371 | $59.81 |
| Q1 2023 | -1,584 | Reduce 1.31% | 119,787 | $54.10 |
| Q2 2023 | -11,704 | Reduce 9.77% | 108,083 | $67.71 |
| Q3 2023 | -38,553 | Reduce 35.67% | 69,530 | $67.16 |
| Q4 2023 | +34,356 | Add 49.41% | 103,886 | $66.72 |
| Q1 2024 | -42,923 | Reduce 41.32% | 60,963 | $82.58 |
| Q2 2024 | -3,286 | Reduce 5.39% | 57,677 | $85.79 |
| Q3 2024 | -41,537 | Reduce 72.02% | 16,140 | $96.64 |
| Q4 2024 | -5,362 | Reduce 33.22% | 10,778 | $92.35 |
| Q1 2025 | -6,545 | Reduce 60.73% | 4,233 | $101.28 |
| Q2 2025 | -970 | Reduce 22.92% | 3,263 | $122.63 |
| Q3 2025 | +54,535 | Add 1671.31% | 57,798 | $127.02 |
Ray Dalio's Encompass Health Corporation Investment FAQs
Ray Dalio first purchased Encompass Health Corporation (EHC) in Q1 2021, acquiring 3,153 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Encompass Health Corporation (EHC) for 19 quarters since Q1 2021. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's largest addition to Encompass Health Corporation (EHC) was in Q2 2021, adding 103,145 shares worth $8.05 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 57,798 shares of Encompass Health Corporation (EHC), valued at approximately $7.34 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Encompass Health Corporation (EHC) represents approximately 0.03% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's peak holding in Encompass Health Corporation (EHC) was 162,387 shares, as reported at the end of Q2 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.